Vesicare and Colon cancer metastatic - a phase IV clinical study of FDA data
Colon cancer metastatic is reported only by a few people who take Vesicare.
The phase IV clinical study analyzes which people take Vesicare and have Colon cancer metastatic. It is created by eHealthMe based on reports of 28,723 people who have side effects while taking Vesicare from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
28,723 people reported to have side effects when taking Vesicare.
Among them, 2 people (0.01%) have Colon cancer metastatic.
What is Vesicare?
Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 29,496 Vesicare users for its effectiveness, alternative drugs and more.
What is Colon cancer metastatic?
Colon cancer metastatic (cancer of colon spreads to other part of body) is found to be associated with 602 drugs and 319 conditions by eHealthMe.
Number of Vesicare and Colon cancer metastatic reports submitted per year:
Gender of people who have Colon cancer metastatic when taking Vesicare *:
- female: 0.0 %
- male: 100 %
Common drugs people take besides Vesicare *:
- Pantoprazole: 2 people, 100.00%
- Melatonin: 2 people, 100.00%
- Lupron Depot: 2 people, 100.00%
- Metoclopramide: 1 person, 50.00%
- Aspirin: 1 person, 50.00%
- Acetaminophen: 1 person, 50.00%
Common side effects people have besides Colon cancer metastatic *:
- Death: 2 people, 100.00%
Common conditions people have *:
- Prostate Cancer: 2 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Vesicare and have Colon cancer metastatic?Check whether Colon cancer metastatic is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Colon cancer metastatic and when was it recovered:
Expand to all the drugs that have ingredients of solifenacin succinate:
Alternative drugs to, pros and cons of Vesicare:
- Vesicare (29,496 reports)
Common Vesicare side effects:
- Drug ineffective: 4,111 reports
- Constipation: 1,854 reports
- Fatigue (feeling of tiredness): 1,609 reports
- Dizziness: 1,265 reports
- Urinary tract infection: 1,160 reports
- Weakness: 1,122 reports
Browse all side effects of Vesicare:a b c d e f g h i j k l m n o p q r s t u v w x y z
Colon cancer metastatic treatments and more:
- Colon cancer metastatic (7,891 reports)
COVID vaccines that are related to Colon cancer metastatic:
- Colon cancer metastatic in Moderna COVID Vaccine
- Colon cancer metastatic in Pfizer BioNTech Covid Vaccine
- Colon cancer metastatic in Johnson and Johnson Covid Vaccine
Common drugs associated with Colon cancer metastatic:
- Avastin: 140 reports
- Fluorouracil: 130 reports
- Oxaliplatin: 126 reports
- Humira: 114 reports
All the drugs that are associated with Colon cancer metastatic:
- Colon cancer metastatic (602 drugs)
Common conditions associated with Colon cancer metastatic:
- Colon cancer: 139 reports
- Multiple sclerosis: 128 reports
- Rheumatoid arthritis: 124 reports
All the conditions that are associated with Colon cancer metastatic:
- Colon cancer metastatic (319 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on solifenacin succinate (the active ingredients of Vesicare) and Vesicare (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Nucynta Er and Lexapro drug interaction - a second ago
- Vitamin B and Pathogen Resistance - 3 seconds ago
- Diabetes and Sepsis - 4 seconds ago
- Amaryl and Hypersplenism - 6 seconds ago
- Alendronate Sodium and Rhonchi - 8 seconds ago
- Allegra and Appetite Increased - 9 seconds ago
- Mavik and Zoloft drug interaction - 17 seconds ago
- Alendronate Sodium and Rhinitis - 19 seconds ago
- Alprazolam and Henoch-Schonlein Purpura - 22 seconds ago
- Allegra Allergy and Abdominal Pain - 23 seconds ago